CDX1 and neoplasm: Sodium bisulfite sequencing (BSP) was used to validate the 6 randomly selected candidate islands, in which the results of 5 mapped genes (ANKRD45, CDX1, APC, HOXD3 and TUBB6) showed significant differences in the 10 pairs of validation tumor and adjacent tissue cohorts.